Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of EMSAM 6mg and 12mg in Healthy Volunteers
NCT00532116Phase 4Completed
- Sponsor
- Somerset Pharma
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of selegiline in major depressive disorder (MDD), sponsored by Somerset Pharma. Started Apr 2007; status: completed.
02
Drugs
selegiline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00532116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532116.